George Jr-yuan Chiou, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eye | 35 | 2004 | 729 | 2.370 |
Why?
|
| Interleukin-1 | 18 | 2006 | 1263 | 1.840 |
Why?
|
| Rabbits | 78 | 2011 | 4894 | 1.400 |
Why?
|
| Ocular Hypertension | 16 | 2004 | 198 | 1.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 19 | 2006 | 2282 | 1.070 |
Why?
|
| Retina | 18 | 2004 | 2616 | 1.010 |
Why?
|
| Choroidal Neovascularization | 4 | 2011 | 343 | 0.970 |
Why?
|
| Intraocular Pressure | 28 | 2004 | 1270 | 0.970 |
Why?
|
| Uveitis | 10 | 2000 | 375 | 0.940 |
Why?
|
| Pyridazines | 10 | 2006 | 202 | 0.900 |
Why?
|
| Dopamine Antagonists | 10 | 2001 | 296 | 0.850 |
Why?
|
| Nitric Oxide Donors | 5 | 2003 | 121 | 0.820 |
Why?
|
| Ophthalmic Solutions | 22 | 2005 | 317 | 0.660 |
Why?
|
| Flavonoids | 5 | 2004 | 443 | 0.620 |
Why?
|
| Timolol | 13 | 1995 | 52 | 0.610 |
Why?
|
| Nitric Oxide | 7 | 2003 | 2132 | 0.590 |
Why?
|
| Regional Blood Flow | 23 | 2005 | 1525 | 0.590 |
Why?
|
| Ischemia | 12 | 2004 | 1907 | 0.590 |
Why?
|
| Lacrimal Apparatus | 3 | 2003 | 225 | 0.580 |
Why?
|
| Uveitis, Posterior | 5 | 1998 | 44 | 0.540 |
Why?
|
| Retinal Vessels | 13 | 2001 | 772 | 0.540 |
Why?
|
| Retinal Artery | 6 | 2004 | 111 | 0.530 |
Why?
|
| Drugs, Chinese Herbal | 5 | 1997 | 144 | 0.450 |
Why?
|
| Nitric Oxide Synthase | 5 | 2003 | 916 | 0.440 |
Why?
|
| Ciliary Body | 9 | 2003 | 173 | 0.430 |
Why?
|
| Rats | 35 | 2007 | 24260 | 0.400 |
Why?
|
| Prednisolone | 9 | 2006 | 334 | 0.390 |
Why?
|
| Choroid | 9 | 2011 | 322 | 0.390 |
Why?
|
| Quercetin | 1 | 2011 | 93 | 0.370 |
Why?
|
| Animals | 115 | 2011 | 168757 | 0.360 |
Why?
|
| Macular Degeneration | 3 | 2011 | 980 | 0.350 |
Why?
|
| Cornea | 7 | 2000 | 1524 | 0.350 |
Why?
|
| Endophthalmitis | 6 | 1996 | 262 | 0.330 |
Why?
|
| Gallic Acid | 3 | 1997 | 24 | 0.330 |
Why?
|
| Isoflavones | 2 | 1999 | 139 | 0.310 |
Why?
|
| Rats, Long-Evans | 7 | 2004 | 387 | 0.310 |
Why?
|
| Ciliary Arteries | 3 | 2004 | 17 | 0.300 |
Why?
|
| Vasodilator Agents | 3 | 1999 | 977 | 0.300 |
Why?
|
| Conjunctiva | 4 | 1998 | 494 | 0.300 |
Why?
|
| Absorption | 10 | 2005 | 248 | 0.300 |
Why?
|
| Retinal Artery Occlusion | 4 | 1997 | 74 | 0.300 |
Why?
|
| Apigenin | 1 | 2006 | 14 | 0.300 |
Why?
|
| Antioxidants | 2 | 2011 | 1663 | 0.300 |
Why?
|
| Electroretinography | 10 | 2004 | 509 | 0.290 |
Why?
|
| Alkaloids | 4 | 1996 | 190 | 0.290 |
Why?
|
| Insulin | 8 | 2005 | 6580 | 0.280 |
Why?
|
| Coumarins | 4 | 1998 | 119 | 0.270 |
Why?
|
| Glucagon | 4 | 1995 | 533 | 0.270 |
Why?
|
| Blood Flow Velocity | 7 | 1996 | 1423 | 0.270 |
Why?
|
| Imines | 4 | 1999 | 33 | 0.270 |
Why?
|
| Thiazines | 4 | 1999 | 38 | 0.270 |
Why?
|
| Arginine | 3 | 2001 | 944 | 0.270 |
Why?
|
| Haloperidol | 6 | 1993 | 397 | 0.260 |
Why?
|
| Lipoxygenase Inhibitors | 5 | 1991 | 94 | 0.260 |
Why?
|
| Pyrazines | 2 | 2007 | 1230 | 0.250 |
Why?
|
| Isoflurophate | 2 | 1995 | 36 | 0.250 |
Why?
|
| Calcium Channel Blockers | 3 | 1997 | 690 | 0.250 |
Why?
|
| Hydroxides | 1 | 2004 | 47 | 0.250 |
Why?
|
| Crystallins | 7 | 1995 | 75 | 0.250 |
Why?
|
| Glaucoma | 7 | 1995 | 1159 | 0.250 |
Why?
|
| Flavones | 1 | 2004 | 66 | 0.250 |
Why?
|
| Melatonin | 5 | 1993 | 721 | 0.250 |
Why?
|
| Acridines | 3 | 1999 | 19 | 0.240 |
Why?
|
| Nitro Compounds | 2 | 2003 | 74 | 0.240 |
Why?
|
| Cyclic GMP | 2 | 2002 | 409 | 0.240 |
Why?
|
| Pyrazoles | 6 | 2003 | 1972 | 0.240 |
Why?
|
| Endothelium, Vascular | 2 | 2007 | 4456 | 0.230 |
Why?
|
| Fibroblasts | 8 | 2000 | 4161 | 0.230 |
Why?
|
| Uvea | 3 | 1995 | 31 | 0.230 |
Why?
|
| Ocular Hypotension | 2 | 1995 | 22 | 0.230 |
Why?
|
| Fluorescein Angiography | 4 | 2011 | 940 | 0.230 |
Why?
|
| Trabeculectomy | 2 | 1995 | 160 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2000 | 8301 | 0.220 |
Why?
|
| Eye Diseases | 3 | 2001 | 669 | 0.220 |
Why?
|
| Rats, Inbred BN | 3 | 2007 | 235 | 0.210 |
Why?
|
| Canavanine | 1 | 2001 | 14 | 0.200 |
Why?
|
| Droperidol | 1 | 2001 | 21 | 0.200 |
Why?
|
| Metoclopramide | 1 | 2001 | 51 | 0.200 |
Why?
|
| Administration, Topical | 9 | 1996 | 690 | 0.200 |
Why?
|
| Polyethylene Glycols | 8 | 1995 | 1182 | 0.190 |
Why?
|
| Accommodation, Ocular | 1 | 2001 | 48 | 0.190 |
Why?
|
| Carbachol | 1 | 2001 | 226 | 0.190 |
Why?
|
| Indomethacin | 3 | 1991 | 332 | 0.190 |
Why?
|
| Hydrazines | 3 | 1998 | 226 | 0.190 |
Why?
|
| Iris | 6 | 2003 | 239 | 0.180 |
Why?
|
| Endotoxins | 4 | 1996 | 527 | 0.180 |
Why?
|
| Muscle, Smooth | 2 | 2001 | 934 | 0.180 |
Why?
|
| Blood Glucose | 9 | 2005 | 6256 | 0.170 |
Why?
|
| Propanolamines | 2 | 1995 | 167 | 0.170 |
Why?
|
| Endothelin-1 | 1 | 2001 | 314 | 0.170 |
Why?
|
| Domperidone | 3 | 1992 | 23 | 0.170 |
Why?
|
| Quinolines | 3 | 1991 | 732 | 0.170 |
Why?
|
| Injections, Intraperitoneal | 4 | 2007 | 425 | 0.170 |
Why?
|
| Eye Proteins | 1 | 2002 | 646 | 0.160 |
Why?
|
| Instillation, Drug | 4 | 2004 | 32 | 0.160 |
Why?
|
| Echo-Planar Imaging | 1 | 2003 | 659 | 0.160 |
Why?
|
| Dry Eye Syndromes | 1 | 2003 | 386 | 0.160 |
Why?
|
| Myopia | 1 | 2001 | 254 | 0.160 |
Why?
|
| Oxymetazoline | 1 | 1997 | 5 | 0.160 |
Why?
|
| Disease Models, Animal | 13 | 2007 | 18029 | 0.150 |
Why?
|
| Hydroxyquinolines | 2 | 1989 | 19 | 0.150 |
Why?
|
| Microspheres | 5 | 2004 | 777 | 0.150 |
Why?
|
| Reperfusion Injury | 1 | 2004 | 1026 | 0.150 |
Why?
|
| Nitroso Compounds | 1 | 1997 | 72 | 0.150 |
Why?
|
| Oxadiazoles | 1 | 1997 | 93 | 0.150 |
Why?
|
| Dopamine Agents | 3 | 1993 | 189 | 0.150 |
Why?
|
| Cells, Cultured | 11 | 2007 | 19229 | 0.150 |
Why?
|
| Trifluperidol | 3 | 1992 | 3 | 0.150 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1997 | 177 | 0.140 |
Why?
|
| Recovery of Function | 2 | 2004 | 2925 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2007 | 10481 | 0.140 |
Why?
|
| Blood-Aqueous Barrier | 1 | 1996 | 7 | 0.140 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 1995 | 675 | 0.140 |
Why?
|
| Benzylisoquinolines | 1 | 1996 | 15 | 0.140 |
Why?
|
| Hypoglycemia | 3 | 1995 | 861 | 0.140 |
Why?
|
| Dark Adaptation | 5 | 2000 | 219 | 0.140 |
Why?
|
| Conjunctivitis | 1 | 1997 | 158 | 0.140 |
Why?
|
| Hesperidin | 1 | 1996 | 16 | 0.140 |
Why?
|
| Hyperemia | 1 | 1997 | 225 | 0.140 |
Why?
|
| Cell Division | 8 | 2000 | 4568 | 0.140 |
Why?
|
| Carotenoids | 1 | 1999 | 624 | 0.130 |
Why?
|
| Mydriatics | 1 | 1996 | 68 | 0.130 |
Why?
|
| Umbilical Veins | 2 | 2007 | 433 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 12 | 2003 | 10943 | 0.130 |
Why?
|
| Enzyme Inhibitors | 3 | 2002 | 3798 | 0.130 |
Why?
|
| Butanones | 1 | 1995 | 27 | 0.130 |
Why?
|
| Receptors, Interleukin-1 | 3 | 2003 | 262 | 0.120 |
Why?
|
| Laser Coagulation | 2 | 2007 | 326 | 0.120 |
Why?
|
| Peptides | 3 | 1994 | 4409 | 0.120 |
Why?
|
| Cattle | 4 | 2006 | 3922 | 0.120 |
Why?
|
| Glutathione | 1 | 1997 | 589 | 0.120 |
Why?
|
| Cell Movement | 1 | 2006 | 5217 | 0.120 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 1995 | 1240 | 0.120 |
Why?
|
| Radioimmunoassay | 5 | 1993 | 919 | 0.120 |
Why?
|
| Artifacts | 1 | 2003 | 1904 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2007 | 3068 | 0.120 |
Why?
|
| Parasympatholytics | 1 | 1994 | 91 | 0.120 |
Why?
|
| Cholinergic Antagonists | 1 | 1995 | 165 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1997 | 1504 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2006 | 3479 | 0.120 |
Why?
|
| Wound Healing | 2 | 1995 | 2785 | 0.120 |
Why?
|
| Neuroblastoma | 2 | 1995 | 1226 | 0.110 |
Why?
|
| Glaucoma, Open-Angle | 2 | 1994 | 706 | 0.110 |
Why?
|
| Periodicals as Topic | 1 | 2004 | 1432 | 0.110 |
Why?
|
| Female | 59 | 2005 | 380194 | 0.110 |
Why?
|
| Monoterpenes | 1 | 1993 | 20 | 0.110 |
Why?
|
| Structure-Activity Relationship | 4 | 2004 | 3129 | 0.110 |
Why?
|
| Injections, Intravenous | 6 | 1993 | 1420 | 0.110 |
Why?
|
| Menthol | 1 | 1993 | 26 | 0.110 |
Why?
|
| Endorphins | 1 | 1993 | 75 | 0.110 |
Why?
|
| Flavanones | 1 | 1993 | 71 | 0.110 |
Why?
|
| Image Enhancement | 2 | 2005 | 2921 | 0.110 |
Why?
|
| Enkephalin, Leucine | 1 | 1992 | 16 | 0.110 |
Why?
|
| Enkephalin, Methionine | 1 | 1992 | 26 | 0.110 |
Why?
|
| Triterpenes | 1 | 1993 | 80 | 0.110 |
Why?
|
| Dog Diseases | 2 | 1991 | 138 | 0.110 |
Why?
|
| Ketanserin | 1 | 1992 | 24 | 0.110 |
Why?
|
| Chalcone | 1 | 1992 | 10 | 0.110 |
Why?
|
| Sorbitol | 1 | 1992 | 59 | 0.100 |
Why?
|
| Enkephalins | 2 | 1993 | 154 | 0.100 |
Why?
|
| Bromocriptine | 1 | 1992 | 111 | 0.100 |
Why?
|
| Hemolysis | 1 | 1994 | 420 | 0.100 |
Why?
|
| Iodates | 1 | 2011 | 2 | 0.100 |
Why?
|
| Sodium Azide | 1 | 2011 | 24 | 0.100 |
Why?
|
| Uveitis, Anterior | 1 | 1992 | 101 | 0.100 |
Why?
|
| Stereoisomerism | 5 | 2003 | 624 | 0.100 |
Why?
|
| beta-Endorphin | 1 | 1991 | 53 | 0.100 |
Why?
|
| Anticoagulants | 2 | 1997 | 4599 | 0.100 |
Why?
|
| Catecholamines | 2 | 1989 | 387 | 0.100 |
Why?
|
| Complement System Proteins | 1 | 1994 | 795 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2003 | 534 | 0.090 |
Why?
|
| Calcitonin | 1 | 1992 | 336 | 0.090 |
Why?
|
| Plant Extracts | 1 | 1994 | 471 | 0.090 |
Why?
|
| DNA | 5 | 2000 | 7301 | 0.090 |
Why?
|
| Gastrointestinal Agents | 1 | 1995 | 494 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 1994 | 1116 | 0.090 |
Why?
|
| Receptors, Adrenergic | 1 | 1989 | 155 | 0.090 |
Why?
|
| Tetrahydronaphthalenes | 1 | 1989 | 89 | 0.090 |
Why?
|
| Calcium | 3 | 1997 | 5756 | 0.090 |
Why?
|
| Fluorophotometry | 3 | 1996 | 40 | 0.090 |
Why?
|
| Prostaglandins | 2 | 1994 | 405 | 0.090 |
Why?
|
| Nalbuphine | 1 | 1989 | 20 | 0.090 |
Why?
|
| RNA | 2 | 1998 | 2749 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2003 | 4042 | 0.090 |
Why?
|
| Vasopressins | 1 | 1991 | 370 | 0.080 |
Why?
|
| Lasers | 2 | 2011 | 952 | 0.080 |
Why?
|
| Morphinans | 1 | 1989 | 31 | 0.080 |
Why?
|
| Naphthalenes | 1 | 1989 | 194 | 0.080 |
Why?
|
| Pupil | 2 | 1991 | 149 | 0.080 |
Why?
|
| Wet Macular Degeneration | 1 | 2011 | 145 | 0.080 |
Why?
|
| Fluoresceins | 3 | 1996 | 235 | 0.080 |
Why?
|
| Sclera | 3 | 1995 | 200 | 0.080 |
Why?
|
| Cell Line | 6 | 2006 | 15997 | 0.080 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 731 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 5751 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1989 | 371 | 0.070 |
Why?
|
| Hemodynamics | 2 | 1991 | 4199 | 0.070 |
Why?
|
| Oxytocin | 1 | 1991 | 394 | 0.070 |
Why?
|
| Depression, Chemical | 2 | 2003 | 191 | 0.070 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 225 | 0.070 |
Why?
|
| Neuropeptides | 1 | 1992 | 942 | 0.070 |
Why?
|
| Glycocholic Acid | 1 | 2005 | 3 | 0.070 |
Why?
|
| Fusidic Acid | 1 | 2005 | 15 | 0.070 |
Why?
|
| Fentanyl | 1 | 1989 | 410 | 0.070 |
Why?
|
| Time Factors | 11 | 2005 | 40075 | 0.070 |
Why?
|
| Cataract | 1 | 1992 | 834 | 0.070 |
Why?
|
| Male | 28 | 2007 | 350118 | 0.070 |
Why?
|
| Catheterization, Peripheral | 1 | 1989 | 345 | 0.060 |
Why?
|
| Oxygenases | 1 | 1985 | 60 | 0.060 |
Why?
|
| Hydrogenation | 1 | 2004 | 21 | 0.060 |
Why?
|
| Trimethaphan | 2 | 1995 | 13 | 0.060 |
Why?
|
| Hemicholinium 3 | 2 | 1995 | 8 | 0.060 |
Why?
|
| Hexamethonium | 2 | 1995 | 15 | 0.060 |
Why?
|
| Cell Survival | 3 | 2003 | 5882 | 0.060 |
Why?
|
| Scopolamine | 1 | 2005 | 99 | 0.060 |
Why?
|
| Dopamine | 3 | 1993 | 1591 | 0.060 |
Why?
|
| Dextrans | 1 | 2007 | 595 | 0.060 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 1995 | 226 | 0.060 |
Why?
|
| Muscle Relaxation | 2 | 2001 | 142 | 0.060 |
Why?
|
| Dinoprostone | 4 | 1995 | 600 | 0.060 |
Why?
|
| Pharmacology | 1 | 2004 | 103 | 0.060 |
Why?
|
| Fluorescein | 2 | 1996 | 171 | 0.060 |
Why?
|
| Butyrophenones | 3 | 1992 | 16 | 0.060 |
Why?
|
| Epinephrine | 1 | 1988 | 792 | 0.060 |
Why?
|
| Sympathetic Nervous System | 1 | 1987 | 514 | 0.060 |
Why?
|
| Inflammation | 3 | 2000 | 10638 | 0.060 |
Why?
|
| Amidines | 1 | 2003 | 30 | 0.060 |
Why?
|
| Thiourea | 1 | 2003 | 63 | 0.060 |
Why?
|
| Lipoxygenase | 2 | 1995 | 74 | 0.060 |
Why?
|
| Methylprednisolone | 2 | 1995 | 387 | 0.060 |
Why?
|
| Capillary Permeability | 1 | 2007 | 798 | 0.060 |
Why?
|
| Nitrites | 1 | 2003 | 160 | 0.060 |
Why?
|
| Receptors, Dopamine | 1 | 1984 | 295 | 0.060 |
Why?
|
| Colorimetry | 1 | 2003 | 147 | 0.050 |
Why?
|
| Adenosine | 1 | 1988 | 825 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 1996 | 4149 | 0.050 |
Why?
|
| Detergents | 2 | 1995 | 230 | 0.050 |
Why?
|
| Benzylamines | 1 | 2003 | 223 | 0.050 |
Why?
|
| Dogs | 5 | 2005 | 3912 | 0.050 |
Why?
|
| Algorithms | 1 | 2003 | 13881 | 0.050 |
Why?
|
| Arachidonic Acids | 2 | 1997 | 299 | 0.050 |
Why?
|
| Nitrates | 1 | 2003 | 265 | 0.050 |
Why?
|
| Injections | 2 | 1995 | 840 | 0.050 |
Why?
|
| Aging | 3 | 2005 | 8664 | 0.050 |
Why?
|
| Quinolizines | 3 | 1991 | 19 | 0.050 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2002 | 73 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1992 | 3760 | 0.050 |
Why?
|
| Reserpine | 2 | 1996 | 66 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 1995 | 3265 | 0.050 |
Why?
|
| Biological Availability | 2 | 1993 | 397 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 898 | 0.050 |
Why?
|
| Excipients | 2 | 1992 | 96 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2005 | 1460 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1801 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2001 | 170 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 1989 | 1071 | 0.050 |
Why?
|
| Guinea Pigs | 3 | 1991 | 1386 | 0.050 |
Why?
|
| Quality Control | 1 | 2003 | 841 | 0.040 |
Why?
|
| Sympathomimetics | 2 | 1993 | 57 | 0.040 |
Why?
|
| Lethal Dose 50 | 1 | 1999 | 77 | 0.040 |
Why?
|
| Permeability | 2 | 1992 | 738 | 0.040 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1999 | 70 | 0.040 |
Why?
|
| Taxoids | 1 | 2002 | 666 | 0.040 |
Why?
|
| Glucose | 2 | 1992 | 4397 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 1995 | 5708 | 0.040 |
Why?
|
| Cell Count | 1 | 2003 | 1856 | 0.040 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2003 | 721 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2004 | 1534 | 0.040 |
Why?
|
| Ophthalmology | 1 | 2004 | 508 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2001 | 689 | 0.040 |
Why?
|
| Phantoms, Imaging | 2 | 2003 | 2480 | 0.040 |
Why?
|
| Cell Culture Techniques | 2 | 2003 | 1678 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2004 | 1406 | 0.040 |
Why?
|
| Pilocarpine | 2 | 1989 | 63 | 0.040 |
Why?
|
| S-Nitrosoglutathione | 1 | 1997 | 23 | 0.040 |
Why?
|
| Dinoprost | 2 | 1991 | 138 | 0.040 |
Why?
|
| Water | 1 | 2003 | 1395 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 1997 | 349 | 0.040 |
Why?
|
| Publishing | 1 | 2004 | 833 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1801 | 0.040 |
Why?
|
| Veins | 2 | 1993 | 770 | 0.040 |
Why?
|
| Vasodilation | 1 | 2000 | 944 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2004 | 2740 | 0.040 |
Why?
|
| p-Hydroxyamphetamine | 1 | 1996 | 3 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2006 | 2107 | 0.030 |
Why?
|
| Acetophenones | 1 | 1996 | 48 | 0.030 |
Why?
|
| Surgical Flaps | 2 | 1995 | 1640 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2001 | 1240 | 0.030 |
Why?
|
| Histamine | 1 | 1997 | 507 | 0.030 |
Why?
|
| Pralidoxime Compounds | 1 | 1995 | 5 | 0.030 |
Why?
|
| Cholinesterase Reactivators | 1 | 1995 | 6 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 1995 | 203 | 0.030 |
Why?
|
| Aqueous Humor | 3 | 1991 | 161 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2003 | 5179 | 0.030 |
Why?
|
| Potassium Chloride | 1 | 1995 | 237 | 0.030 |
Why?
|
| Forecasting | 1 | 2004 | 2951 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2003 | 1534 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2002 | 1708 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 2 | 1995 | 1790 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2005 | 35421 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2005 | 2731 | 0.030 |
Why?
|
| Hexamethonium Compounds | 1 | 1994 | 23 | 0.030 |
Why?
|
| Complement Hemolytic Activity Assay | 1 | 1994 | 9 | 0.030 |
Why?
|
| Random Allocation | 1 | 1999 | 2429 | 0.030 |
Why?
|
| Mecamylamine | 1 | 1994 | 29 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 1995 | 5078 | 0.030 |
Why?
|
| Embryo, Mammalian | 2 | 1997 | 1701 | 0.030 |
Why?
|
| Aorta, Thoracic | 2 | 1997 | 1082 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2000 | 2025 | 0.030 |
Why?
|
| Acetyltransferases | 2 | 1985 | 234 | 0.030 |
Why?
|
| Cognition Disorders | 2 | 2005 | 4043 | 0.030 |
Why?
|
| Phenazocine | 1 | 1993 | 7 | 0.030 |
Why?
|
| Cats | 2 | 1986 | 998 | 0.030 |
Why?
|
| Parasympathomimetics | 1 | 1993 | 26 | 0.030 |
Why?
|
| Xylazine | 1 | 1993 | 10 | 0.030 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1993 | 36 | 0.030 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 1993 | 24 | 0.030 |
Why?
|
| Spiperone | 1 | 1992 | 31 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 1994 | 167 | 0.030 |
Why?
|
| Brain | 3 | 2005 | 26385 | 0.030 |
Why?
|
| Humans | 15 | 2006 | 744343 | 0.030 |
Why?
|
| Choline | 1 | 1995 | 493 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 2126 | 0.030 |
Why?
|
| Corneal Diseases | 1 | 2000 | 636 | 0.030 |
Why?
|
| Anterior Eye Segment | 1 | 1994 | 152 | 0.030 |
Why?
|
| Poisoning | 1 | 1994 | 249 | 0.030 |
Why?
|
| Receptors, Opioid | 1 | 1993 | 155 | 0.030 |
Why?
|
| Lipids | 1 | 2003 | 3305 | 0.030 |
Why?
|
| Flavins | 1 | 1992 | 17 | 0.030 |
Why?
|
| Leukotrienes | 1 | 1994 | 255 | 0.030 |
Why?
|
| Cerebral Ventricles | 2 | 2005 | 544 | 0.030 |
Why?
|
| Tonometry, Ocular | 1 | 1993 | 237 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 1995 | 769 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 1993 | 332 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2004 | 3587 | 0.020 |
Why?
|
| Heart Rate | 3 | 1991 | 4091 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 1995 | 1472 | 0.020 |
Why?
|
| DNA Replication | 1 | 1998 | 1399 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 1992 | 380 | 0.020 |
Why?
|
| Necrosis | 1 | 1995 | 1643 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 1992 | 467 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2002 | 2085 | 0.020 |
Why?
|
| Kinetics | 2 | 1989 | 6473 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1992 | 393 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1995 | 1588 | 0.020 |
Why?
|
| Pyrrolidines | 1 | 1993 | 342 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2000 | 13033 | 0.020 |
Why?
|
| Alloxan | 1 | 1990 | 13 | 0.020 |
Why?
|
| Receptors, Catecholamine | 1 | 1989 | 6 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 1991 | 159 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 1984 | 3057 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1992 | 590 | 0.020 |
Why?
|
| Mice | 4 | 2003 | 81183 | 0.020 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 1990 | 50 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 1992 | 388 | 0.020 |
Why?
|
| Leucyl Aminopeptidase | 1 | 1989 | 12 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1995 | 1758 | 0.020 |
Why?
|
| Alfentanil | 1 | 1989 | 27 | 0.020 |
Why?
|
| Saponins | 1 | 1989 | 50 | 0.020 |
Why?
|
| Thymidine | 2 | 2000 | 310 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2005 | 13989 | 0.020 |
Why?
|
| Blood Pressure | 3 | 1991 | 8554 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1989 | 249 | 0.020 |
Why?
|
| Uridine | 2 | 2000 | 146 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 1989 | 6489 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1990 | 647 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1989 | 1157 | 0.020 |
Why?
|
| Papaverine | 1 | 1988 | 46 | 0.020 |
Why?
|
| Models, Biological | 2 | 1995 | 9583 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 4420 | 0.020 |
Why?
|
| Dipyridamole | 1 | 1988 | 145 | 0.020 |
Why?
|
| Theophylline | 1 | 1988 | 132 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 2 | 1985 | 150 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 1994 | 683 | 0.020 |
Why?
|
| Aorta | 1 | 1995 | 2061 | 0.020 |
Why?
|
| Chickens | 2 | 1987 | 865 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 14722 | 0.020 |
Why?
|
| Sympathectomy, Chemical | 1 | 1987 | 22 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 1987 | 248 | 0.020 |
Why?
|
| Myocardial Contraction | 2 | 1984 | 1585 | 0.020 |
Why?
|
| Leucine | 2 | 2000 | 561 | 0.020 |
Why?
|
| Diamines | 1 | 1987 | 59 | 0.020 |
Why?
|
| Aspirin | 1 | 1999 | 3282 | 0.020 |
Why?
|
| Ketamine | 1 | 1993 | 500 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2001 | 12026 | 0.020 |
Why?
|
| Half-Life | 1 | 1988 | 661 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 6314 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 1987 | 352 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1992 | 1205 | 0.020 |
Why?
|
| Analgesics | 1 | 1993 | 1040 | 0.020 |
Why?
|
| Leukocytes | 1 | 1994 | 2043 | 0.020 |
Why?
|
| 7-Alkoxycoumarin O-Dealkylase | 1 | 1985 | 2 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1988 | 2255 | 0.020 |
Why?
|
| Acetylcholine | 1 | 1987 | 621 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 1991 | 1572 | 0.020 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 1985 | 86 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 19905 | 0.020 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1985 | 110 | 0.020 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 1985 | 95 | 0.020 |
Why?
|
| Laser Therapy | 1 | 1991 | 1072 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 1985 | 475 | 0.020 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2004 | 63 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1994 | 2455 | 0.020 |
Why?
|
| Microcirculation | 1 | 1989 | 1286 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1989 | 2557 | 0.010 |
Why?
|
| Binding Sites | 1 | 1993 | 6114 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1985 | 434 | 0.010 |
Why?
|
| Emulsions | 1 | 2003 | 156 | 0.010 |
Why?
|
| Histamine Antagonists | 1 | 1984 | 93 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2005 | 8949 | 0.010 |
Why?
|
| Prostaglandins F | 1 | 1983 | 81 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 1995 | 2219 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1983 | 172 | 0.010 |
Why?
|
| Azoles | 1 | 2002 | 20 | 0.010 |
Why?
|
| Discrimination Learning | 1 | 2004 | 280 | 0.010 |
Why?
|
| Cannabinoids | 1 | 1985 | 166 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1987 | 1619 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1995 | 3703 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 1987 | 906 | 0.010 |
Why?
|
| Isomerism | 1 | 1982 | 201 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2002 | 862 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1987 | 2242 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1986 | 1375 | 0.010 |
Why?
|
| Serotonin | 1 | 1985 | 1017 | 0.010 |
Why?
|
| Atrophy | 1 | 2005 | 1583 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1983 | 494 | 0.010 |
Why?
|
| Reaction Time | 1 | 1987 | 2097 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1985 | 2274 | 0.010 |
Why?
|
| Organ Size | 1 | 2004 | 2252 | 0.010 |
Why?
|
| Brain Mapping | 2 | 2005 | 6669 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 2002 | 836 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 2886 | 0.010 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2002 | 624 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 3508 | 0.010 |
Why?
|
| Models, Animal | 1 | 2005 | 2171 | 0.010 |
Why?
|
| Gadolinium | 1 | 2002 | 952 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 4982 | 0.010 |
Why?
|
| Ryanodine | 1 | 1997 | 47 | 0.010 |
Why?
|
| Hydroquinones | 1 | 1997 | 36 | 0.010 |
Why?
|
| Uracil | 1 | 1998 | 165 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2004 | 1881 | 0.010 |
Why?
|
| Trachea | 1 | 1982 | 1076 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1987 | 8642 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1997 | 909 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2002 | 3479 | 0.010 |
Why?
|
| Reperfusion | 1 | 1995 | 284 | 0.010 |
Why?
|
| Neoplasms | 1 | 2002 | 21683 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1987 | 5985 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1997 | 1792 | 0.010 |
Why?
|
| Clonixin | 1 | 1991 | 1 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2002 | 4851 | 0.010 |
Why?
|
| Hippocampus | 1 | 2004 | 3675 | 0.010 |
Why?
|
| Radiography | 1 | 2002 | 7023 | 0.010 |
Why?
|
| Benzofurans | 1 | 1991 | 140 | 0.010 |
Why?
|
| Leukotriene B4 | 1 | 1991 | 294 | 0.010 |
Why?
|
| Contrast Media | 1 | 2002 | 5300 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 13284 | 0.000 |
Why?
|
| Adult | 1 | 2001 | 214055 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 6364 | 0.000 |
Why?
|
| Proteins | 1 | 2000 | 6103 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 25043 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 2002 | 8863 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2002 | 63114 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 20822 | 0.000 |
Why?
|
| Middle Aged | 1 | 2002 | 213383 | 0.000 |
Why?
|